BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12187774)

  • 1. [Appropriate administration schedule of D-penicillamine for pediatric Wilson's disease patients based on urinary copper excretion].
    Fukuoka N; Morita S; Hamatani S; Okada H; Kondoh M; Imai T; Ohnishi S; Itoh S
    Yakugaku Zasshi; 2002 Aug; 122(8):585-8. PubMed ID: 12187774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of the combined administration of glutathione and D-penicillamine on the urinary copper excretion in Wilson's disease].
    Atsuba Y; Nakahachi T; Terai T; Kozakai T
    No To Shinkei; 1968 Feb; 20(2):187-95. PubMed ID: 5695072
    [No Abstract]   [Full Text] [Related]  

  • 5. Wilson's disease: assessment of D-penicillamine treatment.
    Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
    Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
    Martins da Costa C; Baldwin D; Portmann B; Lolin Y; Mowat AP; Mieli-Vergani G
    Hepatology; 1992 Apr; 15(4):609-15. PubMed ID: 1551638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.
    Dzieżyc K; Litwin T; Chabik G; Członkowska A
    Funct Neurol; 2015; 30(4):264-8. PubMed ID: 26727705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
    Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
    Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral zinc sulphate for Wilson's disease.
    Van Caillie-Bertrand M; Degenhart HJ; Visser HK; Sinaasappel M; Bouquet J
    Arch Dis Child; 1985 Jul; 60(7):656-9. PubMed ID: 4026362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of D,L-penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease).
    LITIN RB; GOLDSTEIN NP; RANDALL RV; POWER MH; DIESSNER GR
    Neurology; 1960 Feb; 10():123-6. PubMed ID: 14417516
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of certain chelating compounds on the urinary excretion of copper by the rat: observations on their clinical significance.
    Gibbs K; Walshe JM
    Clin Sci Mol Med; 1977 Oct; 53(4):317-20. PubMed ID: 913055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary copper excretion and hepatic copper concentrations in liver disease.
    Frommer DJ
    Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary copper excretion after penicillamine in the diagnosis of Wilson's disease in children.
    Gregorio GV; Mieli-Vergani G; Mowat AP
    J Hepatol; 1993 Nov; 19(3):489. PubMed ID: 8151113
    [No Abstract]   [Full Text] [Related]  

  • 15. Penicillamine challenge test in the diagnosis of Wilson's disease.
    Mazumder MW; Karim MB; Rukunuzzaman M
    Mymensingh Med J; 2014 Jul; 23(3):489-95. PubMed ID: 25178601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
    Indaco A; Pellegrino L; Campanella G
    Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
    Hefter H; Kuwert T; Herzog H; Arendt G; Stremmel W; Feinendegen LE
    J Neurol; 1993 Nov; 241(1):49-53. PubMed ID: 8138822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.
    Xu SQ; Li XF; Zhu HY; Liu Y; Fang F; Chen L
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):743-747. PubMed ID: 24142730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.